We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenn Life Sciences Share News (VENN)

  • There is currently no data for VENN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rightmove Chairman sells 7m pounds of shares

Tue, 27th May 2014 15:09

Rightmove's Chairman Scott Forbes has offloaded nearly a half of a holding in the property website group, selling over seven million pounds in shares.Forbes, who has been in his current role since 2005, sold 300,000 shares at an average price of 2,350.81p each, raising a total of £7.05m.Following the deal, his holding was reduced to 319,300 shares, representing a 0.3221% stake in the company.Rightmove said earlier this month that it had made a "positive start" to 2014 as audience continued to grow with page impressions up 14% in the first four months of the year.Meanwhile, the company generated a record 14.8m enquiries for its customers, up 30% on the year, while average revenues per advertiser showed "healthy growth".The business has been boosted over the past year by the recent boom in the UK housing market. However, competition has increased in recent months with rival firm Zoopla announcing its intention to float in June and another property portal called Agent Mutual due to launch next January.Rightmove's shares have fallen by around 15% in the year-to-date but have still risen by nearly 500% since the stock first listed in 2006.Top Director BuysEveryman Media Group (EMAN) Director name: Mr Adam KayeAmount purchased: 207,409 @ 89.00p Value: £184,594REA Holdings (RE.) Director name: Mr David BlackettAmount purchased: 10,000 @ 470.00p Value: £47,000Venn Life Sciences Holdings (VENN) Director name: Mr David Eric EvansAmount purchased: 210,000 @ 20.50p Value: £43,050Dunedin Enterprise Investment Trust (DNE) Director name: Mr Brian FinlaysonAmount purchased: 6,600 @ 429.78p Value: £28,365Wolf Minerals Limited (WLFE) Director name: Mr Russell Clark Amount purchased: 83,333 @ 30.00p Value: £25,000Kea Petroleum (KEA) Director name: Mr Ian Roderick Gowrie-SmithAmount purchased: 865,140 @ 1.95p Value: £16,870NWF Group (NWF) Director name: Mr Philip ActonAmount purchased: 10,000 @ 155.00p Value: £15,500Laird (LRD) Director name: Mr David LockwoodAmount purchased: 4,163 @ 283.59p Value: £11,806Top Director SellsRightmove (RMV) Director name: Mr Scott ForbesAmount sold: 300,000 @ 2,350.81p Value: £7,052,430Grafton Group Units (GFTU) Director name: Mr Gavin SlarkAmount sold: 41,700 @ 585.00p Value: £243,945Hansa Trust 'A' Non Voting Shares (HANA) Director name: Professor Geoffrey WoodAmount sold: 6,500 @ 960.00p Value: £62,400Hansa Trust (HAN) Director name: Professor Geoffrey WoodAmount sold: 5,000 @ 952.00p Value: £47,600Dunedin Enterprise Investment Trust (DNE) Director name: Mr Brian FinlaysonAmount sold: 5,975 @ 475.00p Value: £28,381BC
More News
28 Jun 2019 13:21

Open Orphan Begins London Trading Following Venn Life Merger

(Alliance News) - Shares in Open Orphan PLC began trading in London on Friday following the combination of Venn Life Sciences Holdings PLC and Open Orphan DAC.Venn Life Sciences announced a

Read more
11 Jun 2019 10:51

WINNERS & LOSERS SUMMARY: Ted Baker Sinks After Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 2.5%, BHP Group, up up a

Read more
11 Jun 2019 10:31

Venn Life Sciences Raises GBP4.5 Million As Loss Widens In 2018 (ALLISS)

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Tuesday said it has conditionally raised GBP4.5 million before expenses through a share placing as its loss widened in 2018.The a

Read more
10 May 2019 10:06

Venn Life Sciences To Acquire Open Orphan And Plans To Raise Funds (ALLISS)

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Friday said it is acquiring Open Orphan DAC in an all-share acquisition and planning an equity fundraise.In addition, Venn it has

Read more
8 Apr 2019 12:11

Venn Life Sciences Secures GBP250,000 Loan From Chair Cathal Friel

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Monday said Raglan Capital Ltd, of whom Cathal Friel is a principal and owner, has subscribed for loan notes of GBP250,000 with a term -

Read more
18 Jan 2019 09:44

Venn Life Sciences Partners With Carrick To Develop Cancer Treatments

LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Friday said it has collaborated with Carrick Therapeutics Ltd to develop innovative cancer treatments.The drug development said a

Read more
18 Jan 2019 08:19

Venn Life Sciences finds 'model client' in Carrick Therapeutics

(Sharecast News) - Integrated drug development company Venn Life Sciences announced a partnership with Carrick Therapeutics on Friday.

Read more
11 Dec 2018 14:40

Venn Life Sciences shuffles board, partners with Open Orphan DAC

(Sharecast News) - Integrated drug development company Venn Life Sciences announced a strategic collaboration with Open Orphan DAC, as well as the issue of £1m in privately-held loan notes on Tuesday, to fund an increased focus of the business into the high growth area of orphan diseases.

Read more
11 Dec 2018 12:59

Venn Life Sciences Teams With Open Orphan, Issues GBP1.0 Million Notes

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Tuesday it entered a strategic collaboration with Open Orphan DAC.Under the collaboration, both companies will commit to and to

Read more
25 Sep 2018 13:25

Venn Life Sciences Interim Loss Widens As Order Conversion Disappoints

LONDON (Alliance News) - Drug development firm Venn Life Sciences Holdings PLC said Tuesday its half-year loss widened as revenue dropped on delays to the conversion of orders to sales.For

Read more
30 Jul 2018 16:11

Spreadex Holds 5.5% Stake In Venn Life Sciences After Deal (ALLISS)

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Monday that Spreadex Ltd held a 5.5% stake in the drug developer after a Tuesday transaction.Through a combination of contracts

Read more
4 Jul 2018 11:42

Venn Life Sciences Raises GBP650,000 To Fund German Acquisition (ALLISS)

LONDON (Alliance News) - Drug development partner to pharmaceutical companies Venn Life Sciences Holdings PLC said Wednesday it raised up to GBP650,000 issuing 10.8 million shares at 6 pence was a

Read more
20 Jun 2018 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 21 JuneHSS Hire GroupFriday 22 JuneCambian Fifteen Communications Shipping 25

Read more
17 May 2018 14:32

Venn Life Sciences 2017 Loss Widens On Top Of Lower Revenue

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said on Thursday its loss for 2017 widened due to higher impairments on fixed asset investments, as well as lower revenue for the drug and

Read more
21 Mar 2018 11:03

Venn Life Sciences Searching For New Finance Chief As Hartshorn Leaves

LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Wednesday that Finance Director Jonathan Hartshorn will leave the company, effective immediately, to pursue Venn

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.